Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
PF-00835231 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 71 5
Molnupiravir Emergency use authorization Experimental Antiviral Jan/20/2022 14 1
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 40 4
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
Interferon alfa Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021 6 1
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1